https://www.selleckchem.com/pr....oducts/2,4-thiazolid
independent cardiovascular risk factor by stimulating plasminogen activator inhibitor-1 secretion and blocking fibrinolysis. Hence, proinsulin needs to be evaluated for use as a early marker for diabetes progression.To study the complications of diabetes (microvascular and microvascular) in obese and non obese individuals. Single centre, prospective, observational study comparative study, inclusion 18-65 years, Type 2 DM (WHO criteria). Most common complication was retinopathy (26%), followed by Neuropathy (16%) and Nephro
Aimer
Commentaire
Partagez
